← Back to Search

Active Low-Intensity Transcranial Focused Ultrasound for Dystonia

N/A
Waitlist Available
Led By Robert Chen, MBBS
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Implantation of a Percept PC DBS system at least one month before the sonications
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-minute long recordings at 1) baseline (10 minutes before tus), 2) during tus (lasting either 120 seconds or 40 seconds, depending on the protocol), 3) 10 minutes after tus, 4) 30 minutes after tus, and 5) 45 minutes after tus

Summary

This trial aims to use a non-invasive brain stimulation technique called Transcranial Ultrasound Stimulation (TUS) to target specific areas of the brain in patients with Parkinson's disease and dystonia

Who is the study for?
This trial is for adults with Parkinson's Disease or dystonia, diagnosed by a specialist. Participants must have had a Percept PC DBS system implanted at least one month prior and been on a stable dose of dopaminergic medication for at least four weeks.
What is being tested?
The study tests Transcranial Ultrasound Stimulation (TUS) as a non-invasive alternative to Deep Brain Stimulation (DBS). It aims to modulate brain activity in the globus pallidus internus using TUS while recording local field potentials from previously implanted DBS leads.
What are the potential side effects?
Potential side effects of TUS may include discomfort at the stimulation site, headache, dizziness, or temporary hearing changes. However, since it's non-invasive and targets specific brain areas, risks are considered lower than invasive procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a Percept PC DBS system implanted at least a month ago.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-minute long recordings at 1) baseline (10 minutes before tus), 2) during tus (lasting either 120 seconds or 40 seconds, depending on the protocol), 3) 10 minutes after tus, 4) 30 minutes after tus, and 5) 45 minutes after tus
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-minute long recordings at 1) baseline (10 minutes before tus), 2) during tus (lasting either 120 seconds or 40 seconds, depending on the protocol), 3) 10 minutes after tus, 4) 30 minutes after tus, and 5) 45 minutes after tus for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Any treatment-related adverse events and side effects of TUS applications
Modulations in the amplitude of the LFP power spectrum
Secondary study objectives
Modulations of the aperiodic activities derived from the LFPs

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active Low-Intensity Transcranial Focused UltrasoundActive Control1 Intervention
NeuroFUS device stimulation with 4-channel transducer Stimulation target = GPi Stimulation parameters = 5Hz and 10 Hz protocols at ISPPA=30 W/cm2
Group II: Sham Low-Intensity Transcranial Focused UltrasoundPlacebo Group1 Intervention
NeuroFUS device stimulation with 4-channel transducer Stimulation target = GPi and occipital cortex Stimulation parameters = for the passive sham protocol: GPi target (5Hz and 10 Hz protocols at 0 ISPPA) and for the active sham protocol: occipital target (5Hz and 10 Hz protocol at 30 ISPPA)

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,520 Previous Clinical Trials
503,234 Total Patients Enrolled
6 Trials studying Dystonia
137 Patients Enrolled for Dystonia
Robert Chen, MBBSPrincipal InvestigatorUniversity Health Network, Toronto
3 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Dystonia
25 Patients Enrolled for Dystonia
~4 spots leftby Nov 2025